Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages

Journal of General Virology

Volumn 85, Issue 9, 2004, Pages 2603-2613

  Emori, Yutaka ^a,b   Ikeda, Tamako ^a   Ohashi, Takashi ^a   Masuda, Takao ^a   Kurimoto, Tadashi ^b   Takei, Mineo ^b   Kannagi, Mari ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA CHEMOKINE; BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN BETA; CD4 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRROLIDINE DITHIOCARBAMATE; VIRUS DNA; Z 100;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; LONG TERMINAL REPEAT; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD4; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE DELETION; GENE PRODUCTS, ENV; GENES, NEF; GENETIC VECTORS; HIV-1; HUMANS; INTERFERON-BETA; LIPIDS; MACROPHAGES; MANNANS; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CCR5; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

BACILLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; VESICULAR STOMATITIS VIRUS;

EID: 4544349507     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80046-0     Document Type: Article

References (58)

1. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. & Berger, E. A. (1996). CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
2. Bakri, Y., Schiffer, C., Zennou, V., Charneau, P., Kahn, E., Benjouad, A., Gluckman, J. C. & Canque, B. (2001). The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol 166, 3780-3788.
3. Bernstein, M. S., Tong-Starksen, S. E. & Locksley, R. M. (1991). Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J Clin Invest 88, 540-545.
4. + T cells. Science 270, 1811-1815.
5. Connor, R. I. & Ho, D. D. (1994). Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 68, 4400-4408.
6. da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S. & Ulevitch, R. J. (2001). Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. J Biol Chem 276, 21129-21135.
7. De La Tribonniere, X., Mouton, Y., Vidal, V. & 7 other authors (2003). A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naïve to antiretrovirals. Med Sci Monit 9, PI61-PI68.
8. Deng, H., Liu, R., Ellmeier, W. & 12 other authors (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
9. Descombes, P. & Schibler, U. (1991). A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579.
10. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
11. Emori, Y., Sasaki, H., Hayashi, Y. & Nomoto, K. (1996). Effect of Z-100, an immunomodulator extracted from human type tubercle bacilli, on the pulmonary metastases of Lewis lung carcinoma in attempt to regulate suppressor T cells and suppressor factor, IL-4. Biotherapy 9, 249-256.
12. Fang, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
13. Gaynor, R. (1992). Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6, 347-363.
14. Hale, K. K., Trollinger, D., Rihanek, M. & Manthey, C. L. (1999). Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J Immunol 162, 4246-4252.
15. Hayashi, Y., Ebina, T., Suzuki, F. & Ishida, N. (1981). Interferon-inducing activity of an immunotherapeutic anticancer agent, SSM, prepared from Mycobacterium tuberculosis strain Aoyama B. Microbiol Immunol 25, 305-316.
16. + T cells. Proc Natl Acad Sci U S A 94, 8714-8719.
17. Henderson, A. J., Zou, X. & Calame, K. L. (1995). C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69, 5337-5344.
18. Henderson, A. J., Connor, R. I. & Calame, K. L. (1996). C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5, 91-101.
19. Hill, C. M., Deng, H., Unutmaz, D., Kewalramani, V. N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S. & Littman, D. R. (1997). Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J Virol 71, 6296-6304.
20. Honda, Y., Rogers, L., Nakata, K., Zhao, B-Y., Pine, R., Nakai, Y., Kurosu, K., Rom, W. N. & Weiden, M. (1998). Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188, 1255-1265.
21. Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K. & Akira, S. (2001). Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 166, 5688-5694.
22. Kalter, D. C., Nakamura, M., Turpin, J. A., Baca, L. M., Hoover, D. L., Dieffenbach, C., Ralph, P., Gendelman, H. E. & Meltzer, M. S. (1991). Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol 146, 298-306.
23. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. (1999). Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.
24. Kawamura, I., Mitsuyama, M. & Nomoto, K. (1990). Enhanced protection of cyclophosphamide-treated mice against infection with Pseudomonas aeruginosa after treatment with Z-100, a polysaccharide-rich extract from Mycobacterium tuberculosis Aoyama B. Immunopharmacol Immunotoxicol 12, 331-343.
25. Keesler, G. A., Bray, J., Hunt, J. & 8 other authors (1998). Purification and activation of recombinant p38 isoforms α, β, γ, and δ. Protein Expr Purif 14, 221-228.
26. Kelly, M. D., Naif, H. M., Adams, S. L., Cunningham, A. L. & Lloyd, A. R. (1998). Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 160, 3091-3095.
27. Kobatake, H., Suekane, T., Murakami, Y., Niwa, S., Okahira, A. & Kushida, H. (1981). Studies on hot water extract of Mycobacterium tuberculosis. I. Structural analyses of polysaccharides. Yakugaku Zasshi 101, 713-722.
28. Kobayashi, M., Nakajima, N., Pollard, R. B. & Suzuki, F. (1995). Tumor immunotherapeutic lipid-arabinomannan extracted from Mycobacterium tuberculosis (Z-100) induces the production of IL-12. In Abstracts of the 86th Annual Meeting of the American Association for Cancer Research, Toronto, p. 467.
29. Kobayashi, M., Pollard, R. B. & Suzuki, F. (1997). Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma. Anticancer Drugs 8, 156-163.
30. Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V. & Chen, I. S. (1987). Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819-822.
31. Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C. & Young, P. R. (1997). Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235, 533-538.
32. Lee, J. C. & Young, P. R. (1996). Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59, 152-157.
33. Mancino, G., Placido, R., Bach, S., Mariani, F., Montesano, C., Ercoli, L., Zembala, M. & Colizzi, V. (1997). Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells. J Infect Dis 175, 1531-1535.
34. Maniatis, T., Falvo, J. V., Kim, T. H., Kim, T. K., Lin, C. H., Parekh, B. S. & Wathelet, M. G. (1998). Structure and function of the interferon-β enhanceosome. Cold Spring Harb Symp Quant Biol 63, 609-620.
35. Mann, D. L., Gartner, S., Le Sane, F., Buchow, H. & Popovic, M. (1990). HIV-1 transmission and function of virus-infected monocytes/macrophages. J Immunol 144, 2152-2158.
36. Masuda, T., Planelles, V., Krogstad, P. & Chen, I. S. Y. (1995). Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol 69, 6687-6696.
37. Meylan, P. R. A., Guatelli, J. C., Munis, J. R., Richman, D. D. & Kornbluth, R. S. (1993). Mechanisms for the inhibition of HIV replication by interferons-α, -β, and -γ, in primary human macrophages. Virology 193, 138-148.
38. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci U S A 93, 15341-15345.
39. Natsuka, S., Akira, S., Nishio, Y., Hashimoto, S., Sugita, T., Isshiki, H. & Kishimoto, T. (1992). Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79, 460-466.
40. Oka, H., Emori, Y., Ohya, O., Kobayashi, N., Sasaki, H., Tanaka, Y., Hayashi, Y. & Nomoto, K. (1999). An immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis, Z-100, restores the balance of Th1/Th2 cell responses in tumor bearing mice. Immunol Lett 70, 109-117.
41. Oka, H., Shiraishi, Y., Sasaki, H., Yoshinaga, K., Emori, Y. & Takei, M. (2003). Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12. Biol Pharm Bull 26, 1336-1341.
42. Ono, K. & Han, J. (2000). The p38 signal transduction pathway: activation and function. Cell Signal 12, 1-13.
43. Pauza, C. D., Galindo, J. & Richman, D. D. (1988). Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication. J Virol 62, 3558-3564.
44. Sasaki, H., Schmitt, D., Hayashi, Y., Pollard, R. B. & Suzuki, F. (1993). Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites. Nat Immun 12, 104-112.
45. Sasaki, H., Kobayashi, M., Emori, Y., Ohya, O., Hayashi, Y. & Nomoto, K. (1997). Z-100, a polysaccharide-rich preparation extracted from the human type Mycobacterium tuberculosis, improves the resistance of Meth-A tumor-bearing mice to endogenous septic infection. Biotherapy 10, 139-143.
46. Sasaki, H., Kobayashi, M., Pollard, R. B. & Suzuki, F. (2001). Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Pathobiology 69, 96-103.
47. Smith, P. D., Fox, C. H., Masur, H., Winter, H. S. & Alling, D. W. (1994). Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med 180, 1541-1546.
48. Stephens, J. C., Reich, D. E., Goldstein, D. B. & 36 other authors (1998). Dating the origin of the CCR5-Δ32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62, 1507-1515.
49. + T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli. J Natl Cancer Inst 77, 441-447.
50. Tesmer, V. M., Rajadhyaksha, A., Babin, J. & Bina, M. (1993). NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90, 7298-7302.
51. Tissot, C. & Mechti, N. (1995). Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270, 14891-14898.
52. van't Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A. & 7 other authors (1994). Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 94, 2060-2067.
53. Verani, A., Scarlatti, G., Comar, M., Tresoldi, E., Polo, S., Giacca, M., Lusso, P., Siccardi, A. G. & Vercelli, D. (1997). C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 185, 805-816.
54. Vidal, V. F., Castéran, N., Riendeau, C. J., Kornfeld, H., Darcissac, E. C., Capron, A. & Bahr, G. M. (2001). Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPβ and STAT1: role of CD14 and Toll-like receptors 2 and 4. Eur J Immunol 31, 1962-1971.
55. Wang, X. S., Diener, K., Manthey, C. L. & 10 other authors (1997). Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272, 23668-23674.
56. Weiden, M., Tanaka, N., Qiao, Y. & 14 other authors (2000). Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein β expression. J Immunol 165, 2028-2039.
57. Yee, J. K., Friedmann, T. & Burns, J. C. (1994). Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol 43, 99-112.
58. Zybarth, G., Reiling, N., Schmidtmayerova, H., Sherry, B. & Bukrinski, M. (1999). Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J Immunol 162, 400-406.